Abstract

Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America. Its acute phase is associated with high parasitism, myocarditis and profound myocardial gene expression changes. A chronic phase ensues where 30% develop severe heart lesions. Mouse models of T. cruzi infection have been used to study heart damage in Chagas disease. The aim of this study was to provide an interactome between miRNAs and their targetome in Chagas heart disease by integrating gene and microRNA expression profiling data from hearts of T. cruzi infected mice. Gene expression profiling revealed enrichment in biological processes and pathways associated with immune response and metabolism. Pathways, functional and upstream regulator analysis of the intersections between predicted targets of differentially expressed microRNAs and differentially expressed mRNAs revealed enrichment in biological processes and pathways such as IFNγ, TNFα, NF-kB signaling signatures, CTL-mediated apoptosis, mitochondrial dysfunction, and Nrf2-modulated antioxidative responses. We also observed enrichment in other key heart disease-related processes like myocarditis, fibrosis, hypertrophy and arrhythmia. Our correlation study suggests that miRNAs may be implicated in the pathophysiological processes taking place the hearts of acutely T. cruzi-infected mice.

Details

Title
Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection
Author
Ludmila Rodrigues Pinto Ferreira 1   VIAFID ORCID Logo  ; Frederico Moraes Ferreira 2 ; Laugier, Laurie 3 ; Cabantous, Sandrine 3 ; Isabela Cunha Navarro 4   VIAFID ORCID Logo  ; Darlan da Silva Cândido 4 ; Vagner Carvalho Rigaud 4 ; Juliana Monte Real 5 ; Glaucia Vilar Pereira 6 ; Isabela Resende Pereira 6 ; Ruivo, Leonardo 6 ; Ramendra Pati Pandey 4 ; Savoia, Marilda 4 ; Kalil, Jorge 4 ; Lannes-Vieira, Joseli 6 ; Nakaya, Helder 7 ; Chevillard, Christophe 8 ; Cunha-Neto, Edecio 4   VIAFID ORCID Logo 

 Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil; Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil; Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil; Departamento Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG., Brazil 
 Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil; Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil 
 INSERM, Aix-Marseille University AMU, Faculté de Médecine, Marseille, France 
 Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil; Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil; Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil 
 TUCCA Association for Children and Adolescents with Cancer, Department of Pediatric Oncology, Santa Marcelina Hospital, São Paulo, Brazil; Centro de Investigação Translacional em Oncologia, Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil 
 Laboratory of Biology of Interactions, Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil 
 Department of Pathophysiology and Toxicology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA 
 INSERM, Aix-Marseille University AMU, Faculté de Médecine, Marseille, France; INSERM, Aix-Marseille University AMU, UMR1090, Parc Scientifique de Luminy case 928, 163 avenue de Luminy, Marseille, France 
First page
1
Publication year
2017
Publication date
Dec 2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1983424348
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.